RT Journal Article
T1 Primary prevention implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator in elderly patients: results of a Spanish multicentre study.
A1 Expósito, Víctor
A1 Rodríguez-Mañero, Moisés
A1 González-Enríquez, Susana
A1 Arias, Miguel A
A1 Sánchez-Gómez, Juan Miguel
A1 Andrés La Huerta, Ana
A1 Bertomeu-González, Vicente
A1 Arce-León, Álvaro
A1 Barrio-López, María Teresa
A1 Arguedas-Jiménez, Hugo
A1 Seara, Javier García
A1 Rodriguez-Entem, Felipe
K1 Cardiac resynchronization therapy
K1 Elderly
K1 Implantable cardioverter-defibrillator
K1 Primary prevention
K1 Survival
AB Currently, there continues to be a lack of evidence regarding outcomes associated with device-based therapy for ventricular arrhythmias in elderly patients, even more in primary-prevention indications. We aimed to describe the follow-up in terms of efficacy and safety of implantable cardioverter-defibrillator (ICD) therapy in a large cohort of elderly patients. Retrospective multicentre study performed in 15 Spanish hospitals. Consecutive patients referred for ICD implantation before 2011 were included. One hundred and sixty-two of 1174 patients (13.8%) ≥75 years were considered as 'elderly'. When compared with those patients  In a real-world scenario, elderly patients comprise ∼15% of ICD implantations for primary prevention of sudden cardiac death (SCD). Although the rate of appropriate therapy is similar between groups, the benefit of ICD is attenuated for a major increase in mortality risk among those patients ≥75 years at the moment of device implantation.
YR 2015
FD 2015-11-12
LK http://hdl.handle.net/10668/9620
UL http://hdl.handle.net/10668/9620
LA en
DS RISalud
RD Apr 7, 2025